683 related articles for article (PubMed ID: 28494740)
1. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
Nafee N; Gouda N
Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
3. Non-viral Delivery Systems for Breast Cancer Gene Therapy.
Vaseghi G; Rafiee L; Javanmard SH
Curr Gene Ther; 2017; 17(2):147-153. PubMed ID: 28595562
[TBL] [Abstract][Full Text] [Related]
4. Gene Delivery Particle Engineering Strategies for Shape-dependent Targeting of Cells and Tissues.
Kozielski KL; Sitti M
Curr Gene Ther; 2017; 17(2):80-88. PubMed ID: 28494739
[TBL] [Abstract][Full Text] [Related]
5. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
[TBL] [Abstract][Full Text] [Related]
6. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
7. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
Castillo RR; Baeza A; Vallet-Regí M
Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
9. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances.
Rehman Zu; Zuhorn IS; Hoekstra D
J Control Release; 2013 Feb; 166(1):46-56. PubMed ID: 23266451
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
Vaughan HJ; Green JJ; Tzeng SY
Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
12. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
13. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
[TBL] [Abstract][Full Text] [Related]
14. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.
Peluffo H; Unzueta U; Negro-Demontel ML; Xu Z; Váquez E; Ferrer-Miralles N; Villaverde A
Biotechnol Adv; 2015; 33(2):277-87. PubMed ID: 25698504
[TBL] [Abstract][Full Text] [Related]
15. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
[TBL] [Abstract][Full Text] [Related]
16. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics.
Ferreira D; Fontinha D; Martins C; Pires D; Fernandes AR; Baptista PV
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751935
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?
Aigner A; Kögel D
Nanomedicine (Lond); 2018 Jan; 13(1):89-103. PubMed ID: 29199893
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional enveloped nanodevices (MENDs).
Sato Y; Nakamura T; Yamada Y; Akita H; Harashima H
Adv Genet; 2014; 88():139-204. PubMed ID: 25409606
[TBL] [Abstract][Full Text] [Related]
20.
Gallego L; Ceña V
Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
